AHF Epidemiology Readmissions Reduction Program.

Slides:



Advertisements
Similar presentations
Collaborative on Reducing Readmissions in Florida May 2011.
Advertisements

Where Are We on the Path to Elimination of Chronic Hepatitis C?
Optimization of pre-ESRD care: The key to improved dialysis outcomes
The Nurse’s Role in Inflammatory Bowel Disease
Emerging Concepts in Heart Failure
Hospitalizations and Healthcare Costs Need for Reduction in Hospitalizations of Patients With HF
Characteristics of research
ICD-10 and Clinical Documentation
Optimizing Outcomes in Short Bowel Syndrome With IF
Acute Heart Failure.
Hyperkalemia in the Hospital: Collaboration to Improve Transitions of Care.
Heart Failure and Hospital Readmissions
Preventing SCD With a WCD: Reviewing the Results of the VEST Trial
Heart Rate, HF Admissions, and Readmissions
Improving Management of Rosacea From Therapeutics to Routine Skin Care
RSV Bronchiolitis.
Renal and Extrarenal Complications of ADPKD: Facilitating Better Patient Care.
Progressive Fibrosing Interstitial Lung Diseases – Addressing the Challenges Concept of Progressive Fibrosing ILDs With Examples.
Patient-Centered Care in Cystic Fibrosis
Recurrent Angina: New Tools for an Old Problem
New Data in nAMD: What Does the Future Hold?
PAH Therapy Revisited.
Time to Take Gout Seriously
Talking to Patients About Diabetes Management
Case Study. Managing Medication and Adherence in SIHD: Partnering With the Patient to Improve Care.
Identifying and Treating Patients With SBS-IF
WHO Clinical Classification of PH Complex Cases in PH.
Clinical Pearls on the Management of Immune-Mediated Adverse Events Affecting the Genitourinary Tract.
Preventing Heart Failure Readmission and Progression
A Case-based Approach to RSV Disease
From Start to Finish: Initial and Ongoing Care for Men Receiving PrEP
Patient Selection, Pharmacoeconomics, and PCSK9 Inhibitors
Remote Patient Management:
Introduction. Exploring Strategies for Recognition and Management of Lower Limb Spasticity in Children.
Learning Objectives CMS Measures in HF: 30-day Hospital Readmission Rates.
Revisiting the Pharmacoeconomics of HF
Improving 30-Day HF Readmission Rates With Biomarker-Guided Therapy
Background. Advancing the Care of Patients With Moderate to Severe Atopic Dermatitis: A Case-Based Discussion.
Novel Insulin/GLP-1 Combinations: Of Interest to the Primary Care Physician?
Heart Failure. Enhancing Myosin Activation and Cardiac Contractility: Implications for Heart Failure.
New Strategies to Reduce HF Readmissions
EGPA.
Statins, Obesity, and Hyperlipidemia
Epidemiology of opportunistic infections in AIDS patients
The Adherence Challenge in Schizophrenia Roles of Current and Emerging Therapies.
A Nursing Perspective on Improving Outcomes for Patients With Hemophilia.
Volume 72, Issue 9, Pages (November 2007)
Improving Adherence to Antiplatelet Therapy After an ACS Event
Clinical Challenges and Updates in Managing Seizure Clusters
Assessing the Burden of Hyperkalemia
Renal Function and Myeloma Therapeutics
Contemporary Considerations in Biomarker-Guided Therapy
So Many Guidelines, So Little Time:
HF-Related Hospitalization and Readmissions
AMD Therapy: Where Are We Now and Where Are We Going?
Clinical Challenges in the Patient With Relapsed Multiple Myeloma
Assessing the Burden of Hyperkalemia
Updates on Dyslipidemia
Evaluating the Science of Cardiogenic Shock
Pulmonary Arterial Hypertension and Hospitalizations
Lipids, the Heart, and the Kidney
My PAH Patient.
Optimization of pre-ESRD care: The key to improved dialysis outcomes
The Real Burden of Rosacea
Navigating the Journey
Case-Based Look at Hyperkalemia Identification, Diagnosis, and Management.
Fresh perspectives ON BASAL Insulins in diabetes care
What's New in NOACs in AF?.
Best Practices in Building HIV Care Networks
Presentation transcript:

AHF Epidemiology

Readmissions Reduction Program

Demographic and Clinical Characteristics of AHF Patients

Short-term Morbidity and Mortality of AHF

Problems of Traditional Approach With Diuresis

Common Problems to Address

Pathophysiology of AHF Congestion Multifactorial Process

Understanding AHF Congestion

Troponin Release

Studies Aimed to Remove Volume Yet Maintain or Improve Renal Function

Omecamtiv Mecarbil: ATOMIC-AHF

Current and Emerging Therapies

RELAX-AHF Study Design

RELAX-AHF Points for Discussion

Interdisciplinary Team-based Care

Abbreviations

Abbreviations (cont)

References

References (cont)

References (cont)

References (cont)